These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25037050)

  • 1. Fecal metabolomics: assay performance and association with colorectal cancer.
    Goedert JJ; Sampson JN; Moore SC; Xiao Q; Xiong X; Hayes RB; Ahn J; Shi J; Sinha R
    Carcinogenesis; 2014 Sep; 35(9):2089-96. PubMed ID: 25037050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
    Sinha R; Ahn J; Sampson JN; Shi J; Yu G; Xiong X; Hayes RB; Goedert JJ
    PLoS One; 2016; 11(3):e0152126. PubMed ID: 27015276
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.
    Sun Y; Zhang X; Hang D; Lau HC; Du J; Liu C; Xie M; Pan Y; Wang L; Liang C; Zhou X; Chen D; Rong J; Zhao Z; Cheung AH; Wu Y; Gou H; Wong CC; Du L; Deng J; Hu Z; Shen H; Miao Y; Yu J
    Cancer Cell; 2024 Aug; 42(8):1386-1400.e8. PubMed ID: 39137727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive fecal metabonomic detection of colorectal cancer.
    Phua LC; Chue XP; Koh PK; Cheah PY; Ho HK; Chan EC
    Cancer Biol Ther; 2014 Apr; 15(4):389-97. PubMed ID: 24424155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
    Williams MD; Xian L; Huso T; Park JJ; Huso D; Cope LM; Gang DR; Siems WF; Resar L; Reeves R; Hill HH
    J Proteome Res; 2016 Dec; 15(12):4176-4187. PubMed ID: 27696867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
    Bever AM; Hang D; Lee DH; Tabung FK; Ugai T; Ogino S; Meyerhardt JA; Chan AT; Eliassen AH; Liang L; Stampfer MJ; Song M
    J Natl Cancer Inst; 2024 Jul; 116(7):1126-1136. PubMed ID: 38430005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
    Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
    Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
    Weir TL; Manter DK; Sheflin AM; Barnett BA; Heuberger AL; Ryan EP
    PLoS One; 2013; 8(8):e70803. PubMed ID: 23940645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
    Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies.
    Loftfield E; Vogtmann E; Sampson JN; Moore SC; Nelson H; Knight R; Chia N; Sinha R
    Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1483-1490. PubMed ID: 27543620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.
    Wang HP; Wang YY; Pan J; Cen R; Cai YK
    World J Gastroenterol; 2014 Feb; 20(5):1332-9. PubMed ID: 24574808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk.
    Shu X; Cai H; Lan Q; Cai Q; Ji BT; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1634-1642. PubMed ID: 33795214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors.
    Baxter BA; Oppel RC; Ryan EP
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30583518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.